DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Lentz SR, Ehrenforth S, Karim FA. et al; adept™2 investigators.
Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa.
J Thromb Haemost 2014;
12 (08) 1244-1253
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.